All In Biotech

Drug Trial Radar · NCT06730386

A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

A First-in-human, Phase I Study of Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AK138D1 in the Treatment of Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Mar 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Feb 24, 2025

Primary completion

Feb 26, 2028

Study completion Aug 30, 2028

Sponsor

Lead sponsor
AkesoIndustry
Sponsor type
Industry
First posted
Dec 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK138D1 in subjects being treated for advanced solid tumors.

Conditions

  • Solid Cancer

Interventions

  • AK138D1Drug

    Enrolled subjects will receive intravenous infusion (IV) of AK138D1 according to the dosing regimen specified in their cohort.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AEsTime frame: Up to approximately 2 years
  2. Dose-limiting toxicity (DLT)Time frame: Up to approximately 2 years

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Blacktown Hospital-Blacktwon Cancer and Haematology Centre

    Blacktown, New South Wales, Australia · Not yet recruiting

  • Macquarie University

    North Ryde, New South Wales, Australia · Not yet recruiting

  • ICON Cancer Centre South Brisbane

    South Brisbane, Queensland, Australia · Recruiting

  • Peninsula & South Eastern Haematology and Oncology Group

    Frankston, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.